Odierna, D. H., and L. A. Bero. 2009. Systematic reviews reveal unrepresentative evidence for the development of drug formularies for poor and nonwhite populations. Journal of Clinical Epidemiology 62(12):1268–1278.

Oxman, A. D., H. Schunemann, and A. Fretheim. 2006. Improving the use of research evidence in guideline development: Synthesis and presentation of evidence. Health Research Policy and Systems 4:20.

Pocock, S., M. D. Hughes, and R. J. Lee. 1987. Statistical problems in the reporting of clinical trials. A survey of three medical journals. New England Journal of Medicine 317(7):426–432.

PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). 2010. PRISMA endorsers. http://www.prisma-statement.org/endorsers.htm (accessed September 13, 2010).

Roberts, D., and S. Dalziel. 2006. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. In Cochrane Database of Systematic Reviews. http://www.cochrane.org/cochrane-reviews/sample-review#PLS (accessed October 6, 2010).

Roundtree, A. K., M. A. Kallen, M. A. Lopez-Olivo, B. Kimmel, B. Skidmore, Z. Ortiz, V. Cox, and M. E. Suarez-Almazor. 2008. Poor reporting of search strategy and conflict of interest in over 250 narrative and systematic reviews of two biologic agents in arthritis: A systematic review. Journal of Clinical Epidemiology 62(2):128–137

Sacks, H. S., D. Reitman, V. A. Ancona-Berk, and T. C. Chalmers. 1987. Meta–analysis of randomized controlled trials. New England Journal of Medicine 316(8):450–455.

Santesso, N., L. Maxwell, P. S. Tugwell, G. A. Wells, A. M. Connor, M. Judd, and R. Buchbinder. 2006. Knowledge transfer to clinicians and consumers by the Cochrane Musculoskeletal Group. The Journal of Rheumatology 33(11):2312–2318.

Schroter, S., N. Black, S. Evans, J. Carpenter, F. Godlee, and R. Smith. 2004. Effects of training on quality of peer review: Randomised controlled trial. BMJ 328(7441):657–658.

Schroter, S., L. Tite, A. Hutchings, and N. Black. 2006. Differences in review quality and recommendations for publication between peer reviewers suggested by authors or by editors. JAMA 295(3):314–317.

Schünemann, H. J., E. Ståhl, P. Austin, E. Akl, D. Armstrong, and G. H. Guyatt. 2004. A comparison of narrative and table formats for presenting hypothetical health states to patients with gastrointestinal or pulmonary disease. Medical Decision Making 24(1):53–60.

Schwartz, L. M., S. Woloshin, and H. G. Welch. 2009. Using a drug facts box to communicate drug benefits and harms. Annals of Internal Medicine 150(8):516–527.

Shea, B., L. M. Bouter, J. Peterson, M. Boers, N. Andersson, Z. Ortiz, T. Ramsay, A. Bai, V. K. Shukla, and J. M. Grimshaw. 2007. External validation of a measurement tool to assess systematic reviews (AMSTAR). PLoS ONE 2(12):e1350.

Slutsky, J., D. Atkins, S. Chang, and B. A. Collins Sharp. 2010. AHRQ Series Paper 1: Comparing medical interventions: AHRQ and the Effective Health-Care Program. Journal of Clinical Epidemiology 63(5):481–483.

Stroup, D. F., J. Berlin, S. Morton, I. Olkin, G. D. Williamson, D. Rennie, D. Moher, B. J. Becker, T. A. Sipe, S. B. Thacker, and the Meta-analysis of Observational Studies in Epidemiology Group. 2000. Meta-analysis of observational studies in epidemiology: A proposal for reporting. JAMA 283(15):2008–2012.

Trevena, L. J., A. Barratt, P. Butow, and P. Caldwell. 2006. A systematic review on communicating with patients about evidence. Journal of Evaluation in Clinical Practice 12(1):13–23.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement